DE602008004741D1 - Thiophenderivate als medikamente zur behandlung von okularer hypertonie - Google Patents

Thiophenderivate als medikamente zur behandlung von okularer hypertonie

Info

Publication number
DE602008004741D1
DE602008004741D1 DE602008004741T DE602008004741T DE602008004741D1 DE 602008004741 D1 DE602008004741 D1 DE 602008004741D1 DE 602008004741 T DE602008004741 T DE 602008004741T DE 602008004741 T DE602008004741 T DE 602008004741T DE 602008004741 D1 DE602008004741 D1 DE 602008004741D1
Authority
DE
Germany
Prior art keywords
medicaments
treatment
occular
hypertonia
thiophen derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008004741T
Other languages
English (en)
Inventor
Brent A Johnson
David W Old
Yariv Donde
Robert M Burk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of DE602008004741D1 publication Critical patent/DE602008004741D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
DE602008004741T 2007-02-01 2008-01-30 Thiophenderivate als medikamente zur behandlung von okularer hypertonie Active DE602008004741D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88775907P 2007-02-01 2007-02-01
PCT/US2008/052375 WO2008094958A1 (en) 2007-02-01 2008-01-30 Thiophene derivatives useful as medicaments for treating ocular hypertension

Publications (1)

Publication Number Publication Date
DE602008004741D1 true DE602008004741D1 (de) 2011-03-10

Family

ID=39430728

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008004741T Active DE602008004741D1 (de) 2007-02-01 2008-01-30 Thiophenderivate als medikamente zur behandlung von okularer hypertonie

Country Status (6)

Country Link
US (1) US7960431B2 (de)
EP (1) EP2125773B1 (de)
AT (1) ATE496903T1 (de)
DE (1) DE602008004741D1 (de)
ES (1) ES2358558T3 (de)
WO (1) WO2008094958A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102977048A (zh) * 2007-11-09 2013-03-20 阿勒根公司 具有前列腺素活性的取代环戊烷
US9090584B2 (en) 2010-01-26 2015-07-28 Allergan, Inc. Therapeutic agents for treatment of ocular hypertension
US8299068B2 (en) 2010-01-29 2012-10-30 Allergan, Inc. Therapeutically active cyclopentanes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
PL350917A1 (en) * 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
WO2000051977A1 (en) * 1999-03-05 2000-09-08 The Procter & Gamble Company Aldehyde intermediates for the preparation of prostaglandin derivatives
IL143477A (en) 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
US7166730B2 (en) 2000-01-27 2007-01-23 Fine Tech Laboratories, Ltd Process for the preparation of prostaglandin derivatives
US7183310B2 (en) * 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7429669B2 (en) * 2006-06-20 2008-09-30 Allergan, Inc. Therapeutic compounds

Also Published As

Publication number Publication date
EP2125773B1 (de) 2011-01-26
US7960431B2 (en) 2011-06-14
US20100173981A1 (en) 2010-07-08
ATE496903T1 (de) 2011-02-15
EP2125773A1 (de) 2009-12-02
ES2358558T3 (es) 2011-05-11
WO2008094958A1 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
ATE517882T1 (de) Chinolinderivate
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
IL180495A (en) Benzyl triazolone compounds as non-nucleotide reverse transcriptase inhibitors
DE602005023015D1 (de) Indolderivate als viruzide
DE602004024880D1 (de) Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
RS51137B (sr) Derivat benzimidazola i njegova upotreba kao antagonista receptora aii
MA30717B1 (fr) Derives de pyridin-3-yle en tant qu'agents immunomodulateurs
MA30718B1 (fr) Derives de pyridin-4-yle en tant qu'agents immunomodulateurs.
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
EA201000098A1 (ru) Производные хиназолинамида
DE602005021150D1 (de) 3-substituierte pyridinderivate als h3-antagonisten
DE602005008953D1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
ATE384058T1 (de) Thiazolderivate
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
TW200738651A (en) Cyclohexyl sulfonamide derivatives
TW200637817A (en) 5-aminoindole derivatives
EA201000362A1 (ru) Производные 1,3-дигидроизоиндола
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
TW200716547A (en) Piperidin-4-yl-amide derivatives
RU2011112684A (ru) АГЕНТ, СПОСОБСТВУЮЩИЙ РОСТУ ВОЛОС, СОДЕРЖАЩИЙ В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА ПРОИЗВОДНОЕ 15,15-ДИФТОРПРОСТАГЛАНДИНА F2α